​
​

Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?

OverviewForecastRevenueFinancialsChartTranscripts

Taysha Gene Therapies Ownership Summary

Taysha Gene Therapies is owned by 68.36% institutional investors, 17.54% insiders, and 14.10% retail investors. Fmr is the largest institutional shareholder, holding 9.17% of TSHA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.18% of its assets in Taysha Gene Therapies shares.

TSHA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTaysha Gene Therapies68.36%17.54%14.10%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S6.52M3.18%38.48K
Fidelity Growth Compy Commingled Pl O6.48M3.16%-
Vanguard Total Stock Mkt Idx Inv4.85M2.37%391.40K
Fidelity Select Biotechnology4.72M2.30%-2.10M
iShares Russell 2000 ETF4.47M2.18%-10.04K
Fidelity Growth Company Fund4.32M2.11%-9.18K
Polar Capital Biotech S Inc3.00M1.46%-
Xtrackers MSCI World Swap ETF 1C2.47M1.20%-
Vanguard Institutional Extnd Mkt Idx Tr2.18M1.06%700.73K
Fidelity Growth Company K61.70M0.83%-29.30K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 27, 2024Manning Paul B-Buy$3.00M
Nov 17, 2023Manning Paul B-Buy$163.00K
Aug 24, 2023Alam Kamran Chief Financial OfficerSell$76.89K
Aug 16, 2023Manning Paul B-Buy$14.82M
Aug 16, 2023Stalfort John A III-Buy$350.00K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q353
2023 Q214

TSHA Ownership FAQ

Who Owns Taysha Gene Therapies?

Taysha Gene Therapies shareholders are primarily institutional investors at 68.36%, followed by 17.54% insiders and 14.10% retail investors. The average institutional ownership in Taysha Gene Therapies's industry, Biotech Stocks , is 45.35%, which Taysha Gene Therapies exceeds.

Who owns the most shares of Taysha Gene Therapies?

Taysha Gene Therapies’s largest shareholders are Fmr (21.21M shares, 9.17%), Rtw investments, lp (18.8M shares, 8.13%), and Avoro capital advisors (18.65M shares, 8.06%). Together, they hold 25.37% of Taysha Gene Therapies’s total shares outstanding.

Does Blackrock own Taysha Gene Therapies?

Yes, BlackRock owns 5.08% of Taysha Gene Therapies, totaling 11.74M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.3M$. In the last quarter, BlackRock increased its holdings by 9.15M shares, a 352.10% change.

Who is Taysha Gene Therapies’s biggest shareholder by percentage of total assets invested?

Acuta capital partners is Taysha Gene Therapies’s biggest shareholder by percentage of total assets invested, with 4.40% of its assets in 2.33M Taysha Gene Therapies shares, valued at 5.22M$.

Who is the top mutual fund holder of Taysha Gene Therapies shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Taysha Gene Therapies shares, with 3.18% of its total shares outstanding invested in 6.52M Taysha Gene Therapies shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools